Trademark Overview
On Tuesday, February 11, 2025, a trademark application was filed for ZEMAIRA with the United States Patent and Trademark Office. The USPTO has given the ZEMAIRA trademark a serial number of 99036259. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, February 11, 2025. This trademark is owned by CSL Behring L.L.C.. The ZEMAIRA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations to treat deficiencies of Alpha One Proteinase inhibitors; Pharmaceutical preparations for transplant conditions; Pharmaceutical preparations for renal conditions; Pharmaceutical preparations for treatment of rejection in transplant recipients; Pharmaceutical preparations for antibody rejection conditions; Pharmaceutical preparations for treatment of emphysema, lung conditions, anti-inflammatory conditions, immunological conditions, and protein deficiencies; Pharmaceutical preparations to prevent and treat graft vs. host disease; Pharmaceutical preparations for Prevention and treatment of Primary Graft Dysfunction